本页面由Tiger Trade Technology Pte. Ltd.提供服务

Odonate Therapeutics LLC

1.12
0.0000
成交量:- -
成交额:- -
市值:4,310.92万
市盈率:-0.41
高:1.12
开:1.12
低:1.12
收:1.12
52周最高:28.41
52周最低:0.8500
股本:3,849.03万
流通股本:2,062.71万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.7114
每股收益(LYR):-3.8448
净资产收益率:-86.14%
总资产收益率:-33.09%
市净率:0.60
市盈率(LYR):-0.29

数据加载中...

2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/01/26

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/01/25

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/01/07

重要事件披露

8-K - Current report
2021/12/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/18

重要事件披露

8-K - Current report
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/05

重要事件披露

8-K - Current report
2021/07/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/25

重要事件披露

8-K - Current report
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]